SBAS Software: First AI-Driven Blood Test Tool to Secure EU-MDR Certification
Smart Blood Analytics Swiss (SBAS) has achieved a significant milestone. Its AI-driven blood test interpretation software, SBAS Software, has become the first of its kind to secure EU-MDR certification. This rigorous assessment ensures the product's safety, quality, and compliance with European Union medical device requirements.
The SBAS Software enhances the speed and accuracy of blood test result interpretation, empowering healthcare professionals with valuable patient health insights. It employs artificial intelligence to boost the accuracy and efficiency of blood test result interpretation, contributing to faster and more accurate medical decisions, ultimately improving patient outcomes.
Dr. Marko Notar, CEO and Founder of SBAS, expressed excitement about the certification. He highlighted the company's commitment to innovation and patient well-being. The EU-MDR certification is a testament to SBAS's dedication to maintaining high standards of safety, performance, and compliance. The company's website can be found at www.smartbloodanalytics.com.
With this certification, SBAS is set to lead advancements in medical diagnostics. As the first clinical decision support software provider to obtain EU-MDR certification for an AI-driven blood test interpretation product, SBAS is transforming the medical diagnostic process and developing new products in this field.
